海森药业 (001367)
Zhejiang Haisen Pharmaceutical Co., Ltd.
K-Line Chart
No K-line data
Stock Details
1. Key Indicators
- Total Shares(W): 15235.12
- Circulating A-Shares(W): 3969.77
- Earnings Per Share(RMB): 0.5900
- Net Assets Per Share(RMB): 9.4267
- Operating Revenue(W RMB): 35886.72
- Total Profit(W RMB): 10236.66
- Net Profit Attributable to Parent(W RMB): 8820.96
- Net Profit Growth Rate(%): 1.45
- Weighted Return on Equity(%): 6.3500
- Operating Cash Flow Per Share(RMB): 0.7060
- Undistributed Profit Per Share(RMB): 3.4357
- Capital Reserve Per Share(RMB): 4.8124
2. Main Business
The main business covers:
- Research, development, production, and sales of chemical pharmaceutical APIs and intermediates.
3. Company Basic Information
- Company Name: Zhejiang Haisen Pharmaceutical Co., Ltd.
- Listing Date: 2023-04-10
- Industry: Pharmaceutical Manufacturing
- Address: Xiangtan Village, Liushi Street, Dongyang City, Zhejiang Province
- Website: www.haisenpharma.com
- Company Profile: The company was restructured into a joint-stock company on October 11, 2017, and is primarily engaged in the research, development, production, and sales of chemical pharmaceutical APIs and intermediates.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | UBS AG | QFII | 50.42 | 1.30 |
| 2 | BARCLAYS BANK PLC | QFII | 44.23 | 1.14 |
| 3 | J.P.Morgan Securities PLC-自有资金 | QFII | 43.85 | 1.13 |
| 4 | Goldman Sachs Group, Inc. | QFII | 27.86 | 0.72 |
| 5 | MORGAN STANLEY & CO. INTERNATIONAL PLC. | QFII | 25.67 | 0.66 |
| 6 | Huatai-PineBridge CSI 2000 Index Enhanced Securities Investment Fund A | Fund | 7.38 | 0.19 |
| 7 | Shenwan Hongyuan Quantitative Small Cap Stock Securities Investment Fund (LOF) A | Fund | 3.04 | 0.08 |
| 8 | Zhong Ou Small Cap Growth Mixed Securities Investment Fund A | Fund | 2.35 | 0.06 |
| 9 | Huatai-PineBridge CSI 1000 Index Enhanced Securities Investment Fund A | Fund | 1.46 | 0.04 |
| 10 | Minsheng Jiayin CSI All Share Index Enhanced Securities Investment Fund A | Fund | 0.71 | 0.02 |
5. Concept Sectors
- Synthetic Biology
- Margin Trading & Securities Lending
- High-Performance Stock
- Individual Shareholding
- Proposed Reduction
- Micro Portfolio Selection
- Micro Small-Cap Stock
Remarks
- Data update date: 2026-01-01
- Data source: Public Market Information
